Boardroom Alpha
Boardroom Alpha
EFX · Current Report (Form 8-K) · Filed April 24, 2026

Equifax Inc — Current Report (Form 8-K)

Form
8-K
Filed
April 24, 2026
Period
Apr 23, 2026
Ticker
EFX
Accession
0001193125-26-177620
Boardroom Alpha · Filing insights

Equifax amends its credit facility, boosting revolver to $2B, swingline to $200M, and extending commitments to 2029.

About Equifax Inc
Market cap
$22.8B
1Y TSR
−24.2%
3Y TSR
−1.6%
Board grade
C
Sector
Industrials
CEO
Mark W Begor
Last annual meeting: May 7, 2026 · View full Equifax Inc profile →
8-K
 
 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): April 23, 2026

 

 

EQUIFAX INC.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Georgia   001-06605   58-0401110

(State or Other Jurisdiction

of Incorporation)

 

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

1550 Peachtree Street, N.W.

Atlanta, Georgia

  30309
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: (404) 885-8000

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading

Symbol

 

Name of each exchange

on which registered

Common stock, $1.25 par value per share   EFX   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 
 


Item 1.01.

Entry into a Material Definitive Agreement.

Amendment to Revolving Credit Agreement

On April 23, 2026, Equifax Inc. (the “Company”) and certain of its subsidiaries, Equifax Limited, Equifax Canada Co., Equifax International Treasury Services Unlimited Company and Equifax Australia Holdings Pty Ltd (collectively, the “Subsidiary Borrowers”), entered into a Fourth Amendment to Credit Agreement (the “Amendment”), which amends the Company’s existing Credit Agreement, dated as of August 25, 2021, among the Company, the Subsidiary Borrowers, the lenders from time to time party thereto and JPMorgan Chase Bank, N.A., as administrative agent (as previously amended, the “Credit Agreement”). The Amendment, among other things, increases the commitments of the unsecured revolving credit facility provided pursuant to the Credit Agreement from an aggregate principal amount of $1.5 billion to aggregate principal amount of $2 billion, increases the swingline loan availability from $150 million to $200 million, and removes the 10 basis point credit spread adjustment applicable to “Term SOFR” borrowings. In addition, the Amendment extends the termination date with respect to $1.9 billion of the aggregate revolving credit facility commitments by one year from August 25, 2028 to August 25, 2029. The termination date with respect to the remaining $100 million of the revolving credit facility commitments is August 25, 2028. Except as amended by the Amendment, the terms of the Credit Agreement remain in full force and effect.

The foregoing description of the Amendment is only a summary, does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is filed as Exhibit 10.1 hereto, and is incorporated herein by reference.

 

Item 2.03.

Creation of a Direct Financial or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.

The information contained in Item 1.01 above is incorporated by reference into this Item 2.03.

 

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit

No.

   Description
10.1    Fourth Amendment to Credit Agreement, dated as of April 23, 2026, by and between Equifax Inc., the designated borrowers party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (filed herewith).
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

EQUIFAX INC.
By:  

/s/ Julia A. Houston

Name:   Julia A. Houston
Title:   Executive Vice President, Chief Legal Officer

Date: April 24, 2026

From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Equifax Inc (EFX)

Reference

Frequently asked questions

When did Equifax Inc file this 8-K?
Equifax Inc (EFX) filed this Current Report (Form 8-K) with the SEC on April 24, 2026. The accession number assigned by EDGAR is 0001193125-26-177620.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Equifax amends its credit facility, boosting revolver to $2B, swingline to $200M, and extending commitments to 2029. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Equifax Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Equifax Inc has filed under CIK 33185, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer